Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension

Sildenafil is a selective inhibitor of phosphodiesterase type 5 (PDE-5). Its chronic administration has been shown to improve exercise capacity, World Health Organization functional class, and haemodynamics in patients with symptomatic pulmonary arterial hypertension (PAH). There is however, no data...

Descripción completa

Detalles Bibliográficos
Autores principales: Keogh, Anne M, Jabbour, Andrew, Hayward, Christopher S, Macdonald, Peter S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605335/
https://www.ncbi.nlm.nih.gov/pubmed/19183760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605335/
https://www.ncbi.nlm.nih.gov/pubmed/19183760

Ejemplares similares